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Summary: Two methods are proposed for the determination of regional concentrations of glutamate in the rat brain
äs well äs in human serum.
Glutamate oxidase was immobilized on non-porous glass beads and glutamate dehydrogenase was immobilized on
glass derivatives. These Supports were employed for the construction of Single Bead String Reactors and Packed
Bed Reactors, respectively, which in turn were linked to Flow Injection Analysis Systems with either photometric
or fluorometric detection. Analytical working curves are linear in the ränge 1—200 / for packed bed reactors
and 10—500 mmol/1 for single bead string reactors. The samples were pretreated depending on their origin and the
applied measuring System. Optimal dilution factors were established for the two techniques. Optimal dilution ratios
were established and the influence of several added substances was investigated. Recovery and method comparison
studies including high performance liquid chromatography verified the accuracy of the proposed methods. Results
frorn within-day and between-day measurements gave relative Standard deviations of 4.7 and 5.9% for serum
samples and 2.5 and 4.0% for brain samples, respectively.
Introduction enzymes (8—11), HPLC (12, 13) and gas chromatogra-
Glutamic acid is considered to be an important neuro- Phymass spectrometry (14, 15). All these methods have
transmitter in the mammalian central nervous System (1) been aPPhed for the determination of glutamic acid m
and the suspicion that it may play a significant role in biological samples with relative success, but they are
the aetiology and pathophysiology of a number of neu- not ««"S* from d^backs such äs the use of compli-
rological and psychiatric disorders (2, 3) has generated cated and/or expensive equipment and the lack of accu-
extra interest in the study of this amino acid. Glutamic racy at low concentrations of glutamic acid in complex
acid concentrations are significantly higher in neoplastic matrices. They also are time consuming, tedious and
ascites than in cardial ascites (4). The increasing trend therefore unsuitable for the rapid routme analysis of
toward the development of analytical methods for reli- lar§e numbers of samples.
able and accurate determination of low glutamic acid ^
 this presentation two methods for the determination
concentration in very small samples is therefore not sur-
 of glutamic acid in human serum and rat brain were
pnsmg. These methods inclüde enzymatic measure,
 used> based on previous investigations (16, 17).
ments with glutamate oxidäse and glutamate dehydroge^
nase2), either alone (5^7) or in combination with other
Materials and Methods
') Funding: STR1DE HELLAS - 33 PROJECT Reagents
2) Enzymes:
Glutamate dehydrogenase (EC 1.4.1.3) All the Chemicals used were of analytical-reagent grade and the
Glutamate oxidase (EC 1.4.3.11) Solutions were prepared in doubly distilled waten Glutamate oxi-
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dase (EC 1.4.3.1) from Strepfomyces sp., 5 U/mg solid was a gift
from Yamasa Shoyu (Chiba-Ken, Japan). Glutamate dehydrogenase
(EC 1.4.1.3) 120 U/mgenzyme protein from beef Hver andnicotin-
amide adenine dinucleotide (NAD+ grade I, 100%) were purchased
from Boehringer Mannheim (Boehringer Mannheim Biochemica,
Germany). The rest of the chemical compounds and the enzyme
Supports (controlled pore glass derivatives and non-porous glass
beads) for the immobil ization, were purchased from Sigma (St
Louis, MO, USA). Glutamic acid Standard Solutions were prepared
from a 0.01 mol/1 stock solution by appropriate dilutions.
Ins t rumenta t ion
Two flow injection analysis Systems, using either single bead string
reactors consisting of non-porous glass beads with immobilized
glutamate oxidase, or packed bed reactors with immobilized gluta-
mate dehydrogenase on Aminopropy l-controlled pore glass and
isothiocyanate-controlled pore glass, were used in connection with
photometric or fluorometric detection, depending on the employed
enzyme. In the second of these enzymatic sytems the NADH gen-
erated is proportional to the original concentration of glutamic acid
and is measured fluorometrically at 460 nm after its excitation at
340 nm. Three values were obtained for each sample, one spectro-
photometrically and two fluorometrically, since the two controlled
pore glass reactors were used separately in the flow injection analy-
sis. The flow injection measurements were performed with a home
made unit used in two different arrangements. The flow injection
analysis set-up consists of a four-way pneumatically actuated injec-
tion valve, an eight channel peristaltic pump and a home made
filter spectrophotometer or a spectrofluorimeter (RF-551, Shi-
madzu, Japan) equipped with low volume flow-through cells (2 μΐ
and 12 μΐ, respectively). The experimental set-ups, which are
shown in figure l, can be thermostated with a controlled water
bath. Data collection and processing was performed with an IBM-
compatible personal Computer and a Software written in Microsoft
Q-Basic. The interface unit was an RTL 800/815 multifunction in-
put-output board.
Preparation.and treatment of the samples
The rats were killed by decapitation and the brains were removed.
The middle brain, the cerebral cortex, the hypothalamus and the
striatum together with substanlia nigra were dissected and rapidly
dropped into liquid nitrogen to minimize post mortem changes.
Amounts of 25-30 mg of the sample were homogenized in 2.0 ml
of 80% cold ethanol in water (normally used for proteinaceous
tissues) under ultrasonication at 45 W for three minutes. The sus-
pension was centrifuged for 10 min at 1370 g, then the supernatant
combined with the washings (3.5 ml total volume) was concen-
trated to dryness under reduced pressure. To the residue were added
l ml of 0.1 mol/1 phosphate buffer pH 8.0 and the resultant Suspen-
sion was filtered through a 0.45 μηι membrane filter to remove the
particulate matter.
The human serum samples were obtained from patients of the loan-
nina University Hospital. Three different methods for the deprotei-
nization of serum samples were employed including either chemi-
cal or physical techniques.
Method (a): Serum sample (500 μΐ) was mixed with 80 μΐ of a 150
g/l zinc sulphate and 300 μΐ of a 50 g/l barium hydroxide. The
mixture was centrifuged and the supernatant was analysed after
appropriate dilution and Ultrafiltration through a membrane with a
nominal weight cut off of Mr 30000 (Millipore, Bedford, M A
01730 USA) for fluid clarification. An excess of the reagents was
necessary for the completion of the precipitation of the proteins.
The time needed to prepare the filtrate was 10 min.
Method (b): Serum sample (400 μΐ) was applied to a Sephadex G-
25 superfine column (Pharmacia, Uppsala, Sweden, 1.5 cm X 4.8
cm). The glutamic acid was eluted with buffer solution, 0.1 mol/1
phosphate pH 8.0. The analyte appears quantitatively between 2.5
and 8.0 ml of the elution volume. This procedure takes only
about 5 min.
Method (c): The serum samples were diluted l : 20 or l : 7 (de-
pending on the applied method, photometric or fluorimetric) with
phosphate buffer and proteins were removed by ultrafiltration
through a membrane with a nominal weight cut off of MT 10 000.
This procedure takes about 15 rnin for the preparation of 300 μΐ of
a protein-free solution.
Analytical procedure
In the case of photometric detection the procedure entails injection
of the sample into the cartier stream and the production of Η2(>2 on
the single bead string reactor containing the immobilized glutamate
oxidase. The reaction mixture meets the Trinder reagent (18) at the
Output of enzymatic reactor and flows through a second single bead
string reactor (40 cm X 0.8 mm), filled with untreated glass beads,
which allows sufficient time for the completion of the reaction.
The maximum of the absorbance-time curve, Amax, is measured
automatically at 510 nm (fig. 1). The working pH of the System is
7.8, the over-all flow rate 0.25 ml/min and the concentrations of
aminoantipyrine, 3,5-dichloro-2-hydroxybenzenesulphonic acid
and peroxidase are 0.4 mrnol/1,1.2 rnmol/1 and 440 000 U/l, respec-
tively. The absorbances measured for the constfuction of the cali-
bration curve were in the r nge 0.030^-0.850. The optimal working
conditions s well s the speciflcity of the analytical method have
been well established in a previous publication (16).
When fluorescence detection is used, the circulating solution with
the sample is driven to a 15 cm mixing single bead string reactor
positioned after the intake of NAD+. The mixture then passes
through the immobilized glutamate dehydrogenase reactor. The
peak height of the fluorescence curve is used for the quantification
of glutamic acid. The optimal pH of the System is 8.0, the overall
flow rate 0.32 ml/min and the final concentration of NAD+ 3.2
mmol/1. A detailed descriptioa of the immobilization procedure is
given elsewhere (17).
The sampling throughput for both Systems is 40 samples per hour
and the required volume for each replicate is 55 μΐ.
Results and Discussion
The enzymatic methods depend on the specificity of
the enzyme and the secondary reactions involved. Ta-
ble l shows the results of the interference study with
15 different compounds. Glutathione, uric acid, ascor-
bic acid (and other reducing compounds, data not
shown) interfere seriously with the photometric
method s they usually do in all procedures involving
peroxidase-hydrogen peroxide Systems (19). Ascorbic
acid is partly auto-oxidized in phosphate buffer to
dehydroascorbic acid. The response of the fluorimetric
System is not affected by the presence of a-ketoghi-
taric acid, ΝΗί and folic acid in concentrations re-
ported in table l, since their normal concentrations in
human serum are ca. 6 μιηοΐ/ΐ, 80 μηαοΐ/ΐ and 30
nmol/1, respectively (20).
Deproteinization of the samples was necessary in order
to avoid any high blanks and double peaks duririg the
measurements. Most of the protein precipitants either
cause undesirable effects that decrease the lifetime of
the reactors, or they cause •proteolysis with rele se of
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(a) Sample
Carrier
Trinder reagcnt Pump
0.21 mi/min
Glutamate
oxidase Reactor
0.04mi/min
»Waste
Computer
(b) Sample
Carrier
NAD+ Pump
0.28 ml/min
Water bath
Reactor l Enzyme [
0.04 ml/min
Waste
Fig. l Flow injection assay set-up for glutamic acid determina-
tion:
(a) Manifold for photometric detection,
(b) Manifold for fluorometric detection,
Computer
Reactor: Single Bead String-Plain Reactor (i. e. reactor filled vvith
untreated glass beads),
D: Detector, Enzyme: glutamate dehydrogenase.
amino acids, which therefore rise to abnormal concen-
tratipns in the serum samples. Precipitation with sulpho-
salicylic acid causes losses of about 20% for all amino
acids (21) while the background absorbance in the
filtrates reaches its highest value during precipitation
with trichloroacetic acid and sodium tungstate (22).
The well established copfecipitation (23) applied in
rriethod (a) was further exploited during our work: effi-
cient removal of proteins and the non-glucose reducing
compounds is a critical condition for the Implementation
of the photometric method and the use of single bead
string reactor bearing the glutamate oxidase. Glutamate
dehydrogenase on the other hand, is susceptible to Ba2^
and Zn2"1" interference.
Ultrafiltration and gel filtration are simpler and faster
approaches for the preparation of protein-free Solutions.
The dilutions of the serum samples prior to their ultrafil-
tration reduces significanüy the time for one analysis,
thus minimizing the probability of hydrolysis of serum
proteins or of glutamine breakdown (24). The final prep-
aration was ultrafiltered and determined by the fluoro-
metric method. In this case, ultrafiltration proved to be
an ideal technique and the recovery of the added glu-
tamic acid was almost complete.
Based on the results of the above mentioned investiga-
tion, the precipitation with zinc sulphate was applied for
the determination of glutamic acid in serum samples
taken from seven adult patients. All alternative methods
for the removal of proteins from the serum samples
proved to be unsuccessful An explanation for this is
probably the presence of reducing interferences in most
of the samples. In contrast, the above assay was feas-
ible, because ultrafiltration aüd gel filtration remove any
optical interference prior to the fluorometry. The results
given in table 2 substantiate the work described above.
The gel filtration procedure, which results in a dilution
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Tab. 1 Effects of several compounds on the assay of glutamic
acid. Standard Solutions of glutamate, 100 μηιοΐ/ΐ for the photomet-
ric and 50 μπιοΐ/ΐ for the fluorometric manifold, were used. The
concentration of each tested compound was 1 mmol/1.
Interfering compound Relative response
Photometric Fluorometric
method method
None 100 100
L-Methionine 100 103
Ζ,-Norvaline 100 112
γ-Aminobutyric acid 100 100
Heparin 102 102
Citrate 101 82
Cholesterol 100 98
Urea 98 99
Uric acid 71 99
Glutathione 46 104
Glutamic ester* 100 102
Peptide lb 101 105
Peptide 2C 101 106
Folie acidd 100 103
α-Ketoglutaric acide 100 98
Ammonium ionf 100 99
a
 HGlu(OMe)OH
b
 Glu-Ile-Asn-Arg-Pro-Asp-Tyr-Leu-Asp-Phe-Ala
Arg-AJa
d
 100nmol/l
e
 30 μηιοΐ/ΐ
f
 300 μιηοΐ/ΐ
Tab. 2 Determination of glutamic acid in serum samples by the
two proposed methods and the HPLC method, in mmol/1. The re-
sults for the fluorometric methods were obtained after ultrafiltra-
tion of the samples. All the results are the average of triplicates
and the errors r nge from 0.01 to 0.03 SD.
Sample Method
Photo- Fluorometric HPLC
meine \U)
Single Amino- Isothio-
bead propyl- cyanate-
string controlled controlled
reactor pore glass pore glass
1 0.18 0.19 0.18 0.19
2 0.12 0.12 0.12 0.11
3 0.39 0.38 0.39 0.39
4 0.17 0.17 0.17 0.16
5 0.37 0.37 0.37 0.37
6 0.36 0.37 0.38 0.37
7 0.21 0.22 0.21 0.23
of the sample 1 : 13.75, gave results very close to the
obtained with the above procedure. If necessary, higher
dilutions were performed, to attain almost undetectable
blank values in the flow injection measurements.
In the case of brain tissue no protein removal or any
other treatment was necessary, since no blank values °
were observed after the dilution of the liquid sample
extracted by the method given above. The photometric
method does not suffer from the above mentioned inter-
ferences. Table 3 gives results of the regional eoiicentra-
tion of glutamic acid obtained by applying the two meth-
ods. All the concentrations f glutamic acid found in the
serum samples and these from different regions of brain
are in good agreement with those obtained by the HPLC
method, omitting the hydrolysis Step (25).
The within-day results and between-day reproducibility
studies in two representative samples (serum sample and
brain tissue) gave the relative Standard deviations for the
two methods which appear in table 4.
The accuracy of the proposed methods was also verified
by recovery studies, in which Standard glutamic acid so-
lutions were added to several samples. Recoveries of
93·^  104% were attained s shown in table 5.
The proposed methods can also be applied for the deter-
mination of glutamic acid in blopd plasma after adding
heparin s anticoagulant to the blood samples.
In conclusion, the two proposed analytical procedures
seem to be sensitive, reproducible, accurate and rela-
tively rapid for the determination of glutamic acid in
serum and brain tissue. The assay can be carried out
with simple and easily available Instrumentation. Con>
pared with the well known HPLC methods, o r methods
offer simplicity and low cost, and they are well suited
to the routine analysis of l rge numbers of samples (40
against 2 samples per hour), without any derivatizatipn.
The reactors are stable when kept in a refrigerator in
buffered phosphate, when not in use. They c ri be used
for more than 3000 rans and retain 75% of their initial
activity after a working period of three months. The de*
tection limits of the proposed methods are comparable
Tab. 3 Glutamic acid concentrations in μιηοΐ/g of wet tissue mea-
sured in several regions pf the rat brain. The data presented are the
means of triphcate measurements by each of the proposed methods.
The SD of the means ranges from 0.1 to 0.3.
Region Method
Photo- Fluorometric HLPC
wi£kfr>is> ' ~ ~ /l C\metnc (13)
Single Amino- Isothio-
bead propyl- cyanate-^
string controlled controlled
reactor pore glass pore glass
Cerebral cortex 10.1 9.3 9.1 -
Hypothalamus 6.3 6.5 6.7 6.6
Middle brain 12.0 12.5 12.7 12.4
Striatum- 9.8 10.3 10.3
Substantia nigra
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Tab. 4 Within-day and between-day relative Standard deviations (CV) for the two methods and two
representative samples.
Sample Within-day CV (%) Between-day CV (%)
Serum (0.37 mmol/1)
Middle Brain (12 μπιοΐ/g)
Photometric
method
5.1 (n = 7)
2.4 (n = 5)
Fluorometric
method
4.0 (n = 7)
2.7 (n = 5)
Photometric
method
6.0 (n = 6)
4.4 (n = 4)
Fluorometric
method
5.8 (n = 6)
3.6 (n = 4)
Tab. 5 Recovery of L-ghitamic acid added to the serum and brain samples analysed in tables 2 and
3, respectively.
Sample, unit Method
Photometric
Fluorometric with
Aminopropyl-controlled pore glass
Serum 1, mmol/1
Serum 7, mmol/1
Hypothalamus, μπιοΐ/g tissue
Middle Brain, μηιοΐ/g tissue
Added
mmol/1
0.15
0.20
5.0
7.0
Taken*
mmol/1
0.33
0.41
11.3
19.0
Found
mmol/1
0.31
0.38
11.3
19.7
Recovery
%
94
93
100
104
Taken*
mmol/1
0.34
0.42
11.5
19.5
Found
mmol/1
0.34
0.41
11.4
19.9
Recovery
%
100
98
99
102
* These concentrations represent the values given in tables 2 and 3 for the respective samples, plus
the added amounts (given under "added" in the table).
with those of the majority of the HPLC techniques (al-
most 0.3 μπιοΐ/ΐ) and adequate for the applications given
above. The enzymatic methods with the soluble enzymes
are not automated and they are uneconomic, because of
the irreversible consumption of the enzymes.
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